Eisai Banzel is FDA-approved to treat seizures related to Lennox-Gastaut syndrome (LGS). It is approved for this use in combination with other seizure medications. It can be prescribed for adults and children ages 1 year and older.

Campaign was developed that showed a graphic representation of Banzel Patients that had greater control of their daily lifes with the support of their caregivers and the conditions associated with LGS.

The brand was developed for the American market and included Logo development, brand guidelines, all digital platforms, print material, packaging, tactical presentations and video.

Eiasi: Banzel

Previous
Previous

Novo Nordisk

Next
Next

Honeywell